Skip to content
Riskpilot
← Back to search
Sign in
Get full access
BOEHRINGER INGELHEIM DANMARK A/S NUF
NUF
Active
Org 932264064
Hagaløkkveien 26, 1383
Asker
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2023
40 employees
Watchlist
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
BOEHRINGER INGELHEIM DANMARK A/S NUF
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
31M
63M
94M
125M
109M
2024
EBITDA
NOK millions
0M
2M
5M
7M
9M
8M
2024
Income statement
NOK thousands
Item
2024
Revenue
109 003
Staff expenses
−55 861
EBITDA
7 804
Depreciation & amort.
−153
EBIT
7 651
Net financials
−810
Profit before tax
6 841
Tax
2 116
Net profit
4 725
Balance sheet
NOK thousands
Item
2024
Total assets
32 049
Equity
4 725
Long-term debt
0
Short-term debt
27 323
Total debt
27 323
Financial ratios
5-year trend
EBITDA margin
7.2%
This company
15.8%
Market median
-54% vs market
2024
2024
Equity ratio
14.7%
This company
38.2%
Market median
-62% vs market
2024
2024
Return on equity
100.0%
This company
18.4%
Market median
+443% vs market
2024
2024
Net profit margin
4.3%
This company
8.1%
Market median
-47% vs market
2024
2024
Asset turnover
3.40×
This company
1.12×
Market median
+204% vs market
2024
2024
Debt / equity
5.78×
This company
0.62×
Market median
-832% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
More on BOEHRINGER INGELHEIM DANMARK A/S NUF
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network